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Abstract
There are suggestions of an inverse association between folate intake and serum folate levels and 
the risk of oral cavity and pharyngeal cancers (OPC), but most studies are limited in sample size, 
with only few reporting information on the source of dietary folate. This study aims to investigate 
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the association between folate intake and the risk of OPC within the International Head and Neck 
Cancer Epidemiology (INHANCE) Consortium.
We analyzed pooled individual-level data from 10 case-control studies participating in the 
INHANCE consortium, including 5,127 cases and 13,249 controls. Odds ratios (ORs) and the 
corresponding 95% confidence intervals (CIs) were estimated for the associations between total 
folate intake (natural, fortification and supplementation) and natural folate only, and OPC risk.
We found an inverse association between total folate intake and overall OPC risk (the adjusted OR 
for the highest versus the lowest quintile was 0.65, 95% CI: 0.43–0.99), with a stronger 
association for oral cavity (OR=0.57, 95% CI: 0.43–0.75). A similar inverse association, though 
somewhat weaker, was observed for folate intake from natural sources only (OR=0.64, 95% CI: 
0.45–0.91).
The highest OPC risk was observed in heavy alcohol drinkers with low folate intake as compared 
to never/light drinkers with high folate (OR=4.05, 95% CI: 3.43–4.79); the attributable proportion 
due to interaction was 11.1%(95% CI: 1.4–20.8%).
The present project of a large pool of case-control studies supports a protective effect total folate 
intake on OPC risk.
Medical Subject Headings (MeSH)
Head and Neck Neoplasms; Meta-Analysis [Publication Type]; Folate
INTRODUCTION
Oral and pharyngeal cancer (OPC) is the seventh most common cancer worldwide, with 
more than half a million cases and about 300,000 deaths in 2012.1 Tobacco smoking and 
alcohol consumption are predominant risk factors for OPC, although other factors, including 
aspects of diet, may affect the risk 2. In particular, a high intake of fruit and vegetables has 
been linked with a lower risk of OPC, whereas a poor nutritional status and unbalanced diet 
have been related to an elevated risk. 2–4 The association between habits and OPC was 
investigated in the International Head and Neck Cancer Epidemiology (INHANCE) 
Consortium.5 Dietary habits reflecting high fruit/vegetable and low red meat intake were 
associated with reduced head and neck cancer risk (per unit score increment, OR = 0.90, 
95% CI: 0.84–0.97).
Folate, also known as vitamin B9, is a water soluble vitamin and is found naturally in green 
leafy vegetables, cereals, legumes and fruits. In humans, folate plays the fundamental role of 
providing methyl groups for denovo deoxynucleotide synthesis and for intracellular 
methylation reactions.6 Only a few case-control studies, however, addressed the effect of 
folate on OPC, with inconsistent results.7–11 Three out of five studies reported no relation 
with risk, 8, 9, 11 while two others found an inverse association.7, 10 However, all these 
studies provided data on natural folate intake only. Folate, in fact, can derive either from 
plant and animal foods (natural folate), from fortified food products, and supplements 
(synthetic folate also known as folic acid).
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Alcohol intake and tobacco consumption are reported to impair folate levels. 12 Alcohol 
perturbs the folate metabolism by reducing folate absorption, increasing folate excretion, or 
inhibiting methionine synthase, 13, 14 while tobacco consumption increases the folate 
turnover in response to the rapid tissue proliferation or DNA repair in aerodigestive tissues 
among smokers. 15, 16
As alcohol and tobacco consumption are the major risk factors for OPC, it is worth assessing 
whether the effect of folate intake on OPC risk is modified by alcohol and tobacco,10, 17, 18 
and whether there is evidence of interaction between variables.
We considered therefore the association between folate intake and the risk of OPC in a 
pooled analysis of case-control studies participating in the INHANCE Consortium, which 
covers populations from Europe, North America and Japan.
MATERIAL AND METHODS
Studies and participants
The INHANCE Consortium was established in 2004 and to date includes 35 head and neck 
cancer case-control studies (several of which are multicenter) for a total of 25,478 cases and 
37,111 controls (data version 1.5).19, 20 Cases included patients with invasive tumors of the 
oral cavity, oropharynx, hypopharynx, larynx, oral cavity or pharynx not otherwise specified 
or overlapping, as defined previously.21, 22 Details on the case-control studies, harmonizing 
questionnaire data and data pooling methods for the INHANCE consortium have been 
previously described. 19, 21 All the studies were performed according to the Declaration of 
Helsinki and were approved by the local ethics committees, according to the legislations at 
study conduction.
In the present analyses, we excluded laryngeal cancer cases and corresponding controls.
All case-control studies in the INHANCE Consortium were eligible for inclusion in the 
current analysis if information on folate intake was available from the corresponding food 
frequency questionnaire (FFQ) for at least 80% of the subjects. Folate and energy intakes 
were estimated using validated study-specific food composition tables.23–27 Subjects who 
lacked information or had inconsistent values on folate intake from FFQ were considered as 
missing. Cases were divided according to the following anatomic sites: 1) oral cavity 
(including lip, tongue, gum, floor of mouth and hard palate); 2) oropharynx (including base 
of tongue, lingual tonsil, soft palate, uvula, tonsil and oropharynx) and hypopharynx 
(including pyriform sinus and hypopharynx); 3) oral cavity, pharynx unspecified or 
overlapping (not otherwise specified, NOS). The main characteristics of the 10 eligible 
studies are reported in Table 1, including 5,127 cases of oral cavity/pharyngeal cancer 
(1,613 of the oral cavity, 2,571 of oropharynx/hypopharynx and 943 of oral cavity/pharynx 
NOS) and 13,249 controls.28–37
The estimate of total folate intake was defined in each study and included at least one of the 
following sources: natural sources of folate, folate-fortified food products and folate 
supplementation. The study-specific definition of total folate intake represented the most 
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accurate proxy of the real intake of folate in each population considered. In detail, among 
the 10 studies included, 6 reported folate estimates exclusively from natural 
sources. 29, 30, 32, 33, 36, 37 Two other studies reported folate estimates from natural sources 
as well as from other combined sources (i.e., natural food sources, folate-fortified food 
products and folate supplementation) 31, 34 and 2 studies reported folate estimates 
exclusively from natural sources and folate supplementation combined.28, 35
Statistical analysis
The main analyses were based on total folate intake, defined as the most complete 
information on folate intake reported in each of the 10 studies. A secondary analysis was 
based on those studies (8 studies) providing information on the natural sources of dietary 
folate only.29–34, 36, 37 For all the analyses, we calculated the study-specific quintiles for 
folate intake among controls. The study-specific cut-off values are reported in Table 1.
The association between folate intake and OPC risk was assessed by estimating the odds 
ratios (ORs) and the corresponding 95% confidence intervals (CIs), using unconditional 
logistic regression model for each case-control study, adjusted for age (quinquennia, 
categorically), gender, education level (no formal education, less than junior high school, 
some high school, high-school graduate, vocational/some college, college graduate/
postgraduate), race/ethnicity (non-Hispanic White, Black, Hispanic/Latino, Asian and 
other), cigarette smoking (never, 1–10, 11–20, 21–30, 31–40, 41–50, >50 pack-years), 
alcohol drinking (non-drinkers, >0–<1, >=1–<3, >=3–<5, >=5 drinks/day) and total energy 
intake (continuous).
The pooled effect estimates from all studies were estimated with fixed-effects and random-
effects logistic regression models.38 We tested for heterogeneity between the study-specific 
ORs by conducting a likelihood ratio test comparing a model that included the product terms 
between each study (other than the reference study) and the variable of interest and a model 
without product terms, for the risk of oral cavity and pharyngeal cancers combined and for 
that of each anatomical subsite. We used the random-effects 38 estimates when 
heterogeneity was detected (p<0.10), and the fixed-effects estimates otherwise. We 
quantified inconsistencies across studies and their impact on the analysis by using 
Cochrane’s Q and the I2 statistic.39, 40
We also conducted a sensitivity analysis, in which each study was excluded one at time to 
ensure that the magnitude of the overall estimates were not dependent on any specific study. 
Subgroup analyses were also conducted by stratifying the results for total folate intake 
according to age, gender, geographic region, education level, study design, cancer subsite, 
body mass index, tobacco status, and alcohol drinking status.
Effect measure modification was evaluated by testing for deviation from a multiplicative 
interaction model, using the log-likelihood ratio test to compare the fit of logistic models 
with and without an interaction term. Biological interaction between alcohol, tobacco 
smoking and total folate intake was estimated using departure from additivity of effects as 
the criterion of interaction, as proposed by Rothman.41 To quantify the amount of 
interaction, the attributable proportion (AP) due to interaction was calculated as described 
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by Andersson et al.42 The AP due to interaction is the proportion of individuals among those 
exposed to the two interacting factors that is attributable to the interaction per se and it is 
equal to 0 in the absence of a biological interaction.
Data analyses were conducted using SAS version 9.2 (SAS Institute, Cary, NC, USA) 
statistical software.
RESULTS
Among the 10 studies included, 3 were conducted in Europe (26% of total cases and 33% of 
controls), 6 in North America (65% of total cases and 44% of controls) and 1 in Japan (9% 
of total cases and 23% of controls). Three studies were based on cancer registry, while the 
remaining ones were hospital-based case-control studies (Table 1). Table 2 reports the 
characteristics of the study population, which included a total of 13,133 men and 5,233 
women (26.7% of cases and 29.2% of all controls were women). Over 78% of cases and 
68% of controls were non-Hispanic white. Cases were more likely cigarette smokers and 
alcohol drinkers than controls (Table 2).
The associations between total folate and folate from natural sources only and OPC risk are 
reported in Table 3. Considering the 10 studies included in the total folate intake analysis, 
the overall ORs of OPC were 0.78 (95% CI: 0.67–0.91) for the second quintile, 0.77 (95% 
CI 0.61–0.96) for the third quintile, 0.72 (95% CI: 0.51–1.01) for the fourth quintile, and 
0.65 (95% CI: 0.43–0.99) for the fifth quintile compared to the first quintile, with a 
significant p-value for trend and heterogeneity between studies. When results were stratified 
by anatomic subsite, the ORs for the highest versus the lowest quintile of total folate intake 
were 0.57 (95% CI: 0.43–0.75), and 0.58 (95% CI: 0.42–0.81) for oral cavity and NOS, 
respectively, with no evidence of heterogeneity across studies. The OR for the highest 
versus the lowest quintile of total folate intake was 0.74 (95% CI: 0.42–1.30) for 
oropharynx/hypopharynx combined, with heterogeneity across studies (p=0.06). 
Considering the 8 studies included in the folate intake from natural sources only, the overall 
ORs of OPC were 0.75 (95% CI: 0.57–1.00) for the second quintile, 0.74 (95% CI: 0.50–
1.10) for the third quintile, 0.70 (95% CI: 0.46–1.06) for the fourth quintile and 0.72 (95% 
CI: 0.46–1.14) for the fifth quintile compared to the first quintile, with heterogeneity across 
studies (p<0.01). When results were stratified by anatomic subsite, the ORs for the highest 
versus the lowest quintile of natural folate intake were 0.64 (95% CI: 0.45–0.91), 0.79 (95% 
CI: 0.44–1.43) and 0.69 (95% CI: 0.36–1.32) for oral cavity, oropharynx/hypopharynx 
combined and NOS, respectively, with evidence of heterogeneity across studies for the latter 
two subsites.
The forest plots depict the pooled and study-specific OR estimates for the associations 
between the highest versus the lowest quintile of total folate intake, considering all cancer 
sites combined and separately (Figure 1). Out of the 10 studies, the ORs of OPC were below 
unity in 8 studies (significant in 4) and above unity in 2 studies (nonsignificant).
Table 4 reports the ORs of OPC for the highest versus the lowest quintile of total folate 
intake according to selected covariates. There was little evidence of notable effect 
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modification, except for a stronger inverse association in the hospital-based studies (OR= 
0.52; 95% CI: 0.40–0.69) compared to the population-based ones (OR= 0.80; 95% CI: 0.63–
1.01) (p for heterogeneity= 0.02).
The analysis of interaction between total folate intake and alcohol reported an OR of 4.05 
(95% CI: 3.43–4.79) for heavy drinkers with a low intake of folate, compared with subjects 
with low alcohol and intermediate/high total folate intake (p for interaction=0.75). Using the 
estimated ORs in Table 5, the attributable proportion (AP) due to interaction is 
(4.05−1.32−3.28+1)/4.05 = 11.1% (95% CI: 1.4%–20.8%). Thus, we estimate that 11.1% of 
OPC cases occurring among heavy drinkers with low folate intake was attributable to 
biological interaction (synergy). As for the interaction between tobacco smoking and folates, 
we reported an OR of 2.73 (95%CI: 2.34–3.19) for those ever tobacco users with a low 
folate intake, compared with subjects with never tobacco users and intermediate/high total 
folate intake (p for interaction=0.90). The AP due to interaction is (2.73−1.33−2.11+1)/2.73 
= 10.6% (95% CI: 0.4%–20.8%), suggesting that 11% of OPC cases occurring among those 
ever smokers and with low folate levels occurred because of the interaction among the risk 
factors.
DISCUSSION
This pooled-analysis of 10 case-control studies including 5,127 OPC cases provided 
evidence of an inverse association between folate intake and OPC risk. The estimated 
association was stronger for oral cavity cancer, with more than 40% risk reduction for the 
highest quintile of folate intake, than for oropharynx/hypopharynx. When pooling the 8 
studies (3,910 OPC cases and 11,805 controls) detailing the solely intake of natural folate 
from diet, however, the inverse association with OPC was no longer significant.
Only a few case-control studies with limited sample sizes considered on the association 
between (natural) folate intake estimated from FFQ and OPC risk.7–11 Little or no 
association was found in three epidemiological studies on this issue conducted in the USA 
(OR=0.7 for the highest versus lowest level of intake, in both men and women),9 Central 
America (OR=1.1, 95% CI: 0.6–2.2)11 and Uruguay (OR=1.3, 95% CI: 0.8–2.2).8 Two 
subsequent case-control studies, one conducted in Italy and Switzerland from 1992 to 
199710 and one in Uruguay from 1996 to 20047, found an inverse association between folate 
intake and OPC risk, with ORs, respectively, of 0.53 (95% CI: 0.40–0.69) and 0.49 (95% CI, 
0.24–0.98) for the highest versus lowest level of intake. Another Italian study reported lower 
serum folate levels in patients with head and neck squamous cell carcinoma (mean value of 
4.9 ng/mL) compared with control groups of non-smokers (mean value of 9.7 ng/mL, p-
value<0.05) and smokers (mean value of 9.1 ng/mL, p-value<0.05).43
The results of our study suggest that total folate intake, including fortified food and 
supplements, is inversely related to OPC risk. Apart from UCLA study, the study-specific 
definition of total folate intake represented the most accurate proxy of the real intake of 
folate in each population considered. In fact, these estimates take into account if 
supplements and/or folate fortified food products were commonly used in each population 
during the enrollment study period. The UCLA Study 30 reported the estimates of natural 
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folate only, but was conducted in a time and in a place where folate fortification in staple 
foods was mandated (after January 1998) and dietary supplement use was popular. For this 
reason, we performed a sensitivity analysis by excluding this study. The pooled OR for the 
highest versus the lowest intake of total folate was 0.62 (95% CI: 0.39–0.98) and was 
similar to the pooled OR when considering all the ten studies (pooled OR=0.65; 95% CI: 
0.43–0.99).
It was not possible, however, to determine how much of this association was due to natural 
or synthetic folate, as information on the intake of the two aforementioned sources was 
detailed only in two studies, with no chance therefore to perform any meaningful sensitivity 
analysis. Interestingly, these studies are the only two that reported an OR above 1 for the 
highest versus the lowest quintile of total folate intake. Since information on natural folate 
intake only was available, we calculated the pooled OR for the highest versus the lowest 
quintile of this folate source. This was 1.25 (95% CI: 0.86–1.83) and thus not substantially 
different from the corresponding pooled OR for total folate intake in these two studies, i.e. 
1.21 (95% CI: 0.87–1.68). Even if it is possible that folic acid may exert a different effect 
than folate in its natural form 44 and it is known that the bioavailability of folic acid from 
supplements is higher than the dietary one, 45 the few available data did not show important 
differences in risks between the two sources of folate.
Due to potential between-countries variations in folate intake, we decided a priori to 
calculate study-specific quintiles of folate intake. However, we also considered the relation 
between OPC and folate intake using absolute cut-offs, based on the distribution of all 
controls combined. Using this approach, the ORs for subsequent quintiles, as compared to 
the lowest one, were 0.69, 0.69, 0.65 and 0.63 for all OPC, and the trend in risk was 
significant. The results were consistent for oral cavity and oropharynx.
Mechanistic evidence provides support for an inverse association between folate intake and 
cancer risk. Folate deficiency may increase the risk of various type of cancers, particularly 
of the gastrointestinal tract 46, through impaired DNA synthesis and disruption of DNA 
methylation that may lead to protoconcogene activation.47 The folate pathway is led by the 
5,10-methylenetetrahydrofolate reductase gene (MTHFR), which converts the 5–10 
methylenetetrahydrofolate to 5-methyltetrahydrofolate, the primary circulating form of 
folate and a cosubstrate for homocysteine methylation to methionine.48 A less active form of 
MTHFR is present among subjects carriers of the homozygous C677T variant, which is 
present in 30% of Caucasians.49 Subjects with impaired enzyme activity have reduced folate 
concentrations, higher serum homocysteine levels, and higher DNA hypomethylation 
compared with those carrying the wild type allele.50 In line with the principle of Mendelian 
Randomization, it is expected that subjects with reduced MTHFR activity are at higher risk 
of OPC in view of the reduced serum folate levels. The distribution of alleles in a population 
is expected to be unrelated to the confounders that may distort observational epidemiologic 
studies because of the random assignment of alleles at the time of gamete formation.51 As 
such, if a functional genetic variant such as C677T of the MTHFR is strongly associated 
with a modifiable exposure (folic acid intake), it can be used to retrieve an unbiased estimate 
of the association of such exposure (e.g., dietary folate) with a disease (e.g., OPC). Two 
meta-analyses on the association between MTHFR and OPC have been published so far, 
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with results showing the absence of an increased risk of cancer among those carrying the 
unfavourable gene variants which is associated with low serum folate levels.52, 53 Taken 
together, the results of our study and those from the functional genetic variants association 
studies suggest that even though folate intake are in principle beneficial toward the risk of 
OPC, this effect might be differential according to the exact source of folate.
In our study we reported an additional excess risk of OPC among those with low folate 
intake that are also heavy drinkers, which is in line with previous findings.10, 17, 18 It has 
been reported that alcohol perturbs folate metabolism by reducing folate absorption, increase 
folate excretion, or inhibiting methionine synthase 14, so it is expected that an additional risk 
of OPC might be present among heavy drinkers with low folate intake. Additionally, our 
results suggest the presence of biological interaction between cigarette tobacco smoke and 
folates, which is in line with previous studies and the biological significance of tobacco in 
inducing cellular proliferation in aerodigestive tissues as a result of the tissue damage. 16 
Assuming that the relationships studied are causal and based on the definition of biological 
interaction between two component causes 41, 54, our results suggest that more than 10% of 
OPC cases among heavy alcohol-drinkers with a low folate intake, and around 10% of OPC 
among those ever smokers with low folate intake have arisen because of the synergistic 
interaction amongst the two component causes. Taken together, these result has important 
implications from a public health point of view, since it shows that by increasing folate 
intake at the population level, even in the presence of harmful lifestyle behaviors (alcohol 
and tobacco), a relevant proportion of OPC cancer might be prevented.
While the present study has its strengths, including its very large size, its capacity to explore 
effect modification by several characteristics and the stratified analyses according to cancer 
subsites, it is not without limitations. Firstly, we were unable to dissect the effect of folate 
on OPC risk according to the intake of supplements or fortified foods. Secondly, the 
investigation might be affected by limitations of case-control studies, including recall bias 
that generally lead to stronger associations between factors and OPC cancer than in cohort 
studies. On the other hand, changes in dietary habits after interview could dilute the risks in 
cohort investigations. Further, we were able to adjust for energy intake in all the studies, 
thus reducing the effect of possible systematic under- or over-reporting. Selection bias in 
case-control studies, especially hospital-based studies, is also a methodological limitation. 
Therefore, the weaker association observed in population-based studies may be more valid. 
Nevertheless, hospital-based case-control studies have the advantage over population-based 
investigations of a higher comparability of information of cases and controls.55 With 
reference to confounding, we were able to allow for major recognized risk factors for OPC 
as well as for total energy intake, but no information was available in the INHANCE data 
version 1.5 on HPV, which is a relevant risk factor for oropharyngeal cancer only. If 
anything, however, the inverse association with folate was stronger for other OPC sites.
In conclusion, findings from this large pooled analysis suggest that high levels of folate 
intake may protect against the risk of OPC, after controlling for potential confounding 
factors, though we cannot rule out selection bias in the hospital-based case-control studies.
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Novelty and impact
There are suggestions of an inverse association between folate and the risk of oral and 
pharyngeal cancer (OPC), but most studies are limited in sample size with only few of 
them reporting information on the source of dietary folate. Using data from INHANCE 
Consortium on over 5000 cases and 13000 controls, we provide convincing evidence that 
folate intake may protect against the risk of OPC, after controlling for recognized 
confounding factors.
Galeone et al. Page 13
Int J Cancer. Author manuscript; available in PMC 2016 February 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1. 
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Table 2
Distribution of oral cavity and pharynx cancer (OPC) cases and controls according to selected variables1 in the 
10 studies included in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium.
OPC cases Controls
n % n %
Age (years)
 <40 237 4.6 739 5.6
 40–44 228 4.5 625 4.7
 45–49 526 10.3 1,043 7.9
 50–54 785 15.3 1,879 14.2
 55–59 953 18.6 2,261 17.1
 60–64 814 15.9 2,148 16.2
 65–69 734 14.3 2,087 15.7
 70–74 542 10.5 1,644 12.4
 ≥75 308 6.0 821 6.2
 p (χ2 test) <0.0001
Sex
 Men 3,753 73.3 9,380 70.8
 Women 1,369 26.7 3,864 29.2
 p (χ2 test) 0.001
Race/ethnicity
 Non-Hispanic white 4,006 78.3 9,064 68.6
 Black 484 9.5 627 4.8
 Hispanic/Latino 122 2.4 308 2.3
 Asian 466 9.1 3,166 24.0
 Other 37 0.7 48 0.3
 p (χ2 test) <0.0001
Education
 No formal 235 4.6 716 5.4
 Less than junior high school 1,117 21.8 4,088 30.9
 Some high school 1,064 20.8 2,003 15.1
 High-school graduate 764 14.9 1,638 12.4
 Vocational school, some college 1,317 25.7 2,749 20.8
 College graduate/postgraduate 627 12.2 2,046 15.4
 p (χ2 test) <0.0001
Cigarette smoking (pack-years)
 Never smokers 919 18.2 5,239 40.2
 1–10 356 7.1 1,788 13.7
 11–20 406 8.0 1,422 10.9
 21–30 583 11.6 1,248 9.6
 31–40 633 12.6 1,136 8.6
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OPC cases Controls
n % n %
 41–50 594 11.8 778 6.0
 >50 1,546 30.7 1,436 11.0
 p (χ2 test) <0.0001
Alcohol intake (drinks/die)
 Non drinkers 646 13.0 3,303 25.6
 >0 – <1 1,143 22.9 4,300 33.4
 >=1 – <3 1,051 21.1 3,035 23.5
 >=3 – <5 710 14.3 1,255 9.7
 >=5 1,425 28.7 1,001 7.8
p (χ2 test) <0.0001
 Body mass index
 <25 kg/m2 2,942 59.4 6,436 48.9
 ≥25 kg/m2 2,014 40.6 6,721 51.1
 p (χ2 test) <0.0001
 Total energy intake (Kcal/die)
 Mean ± SD 1584 ± 1232 1283 ± 939
 p (t-test) <0.0001
1
The sum does not add up to the total because of some missing values
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Table 4
Distribution of cases of oral cavity and pharynx cancer (OPC) and controls, and corresponding odds ratio 
(OR)1 and 95% confidence intervals (CI), for the highest quintile of total folate intake versus the lowest one in 
strata of selected covariates. International Head and Neck Cancer Epidemiology (INHANCE) Consortium.
OPC
Cases2
n:n
Controls2
n:n
OR (95% CI) p for heterogeneity between studies
Age (years)
 <55 350:348 810:751 0.69 (0.40–1.20) <0.01
 ≥ 55 659:603 1615:1680 0.70 (0.44–1.12) 0.03
P for heterogeneity between strata 0.97
Gender
 Men 674:769 1637:1820 0.60 (0.37–0.97) 0.03
 Women 335:182 788:611 0.80 (0.55–1.16) 0.23
P for heterogeneity between strata 0.36
Geographic region3
 Europe 319:233 828:811 0.67 (0.37–1.19) 0.98
 North America 577:667 1010:1020 0.73 (0.58–0.90) 0.22
 Asia 113:51 587:600 0.51 (0.35–0.75) -
P for heterogeneity between strata 0.29
Education
 <high school graduate 325:235 898:908 0.57 (0.40–0.80) 0.24
 ≥high school graduate 684:716 1527:1523 0.71 (0.57–0.87) 0.21
P for heterogeneity between strata 0.28
Study design
 Hospital based 551:387 1663:1664 0.52 (0.40–0.69) 0.66
 Population based 457:564 761:767 0.80 (0.63–1.01) 0.46
P for heterogeneity between strata 0.02
Body mass index4
 <25 kg/m2 638:542 1222:1156 0.61 (0.48–0.79) 0.59
 ≥25 kg/m2 339:394 1186:1262 0.61 (0.33–1.13) 0.03
P for heterogeneity between strata 1.00
Tobacco consumption4,5
 Never tobacco users 141:134 834:874 1.05 (0.48–2.28) <0.01
 Light tobacco users 129:140 527:592 0.74 (0.48–1.14) 0.94
 Heavy tobacco users 696:644 914:813 0.55 (0.43–0.71) 0.47
P for heterogeneity between strata 0.19
Alcohol consumption6
 Never drinkers 140:88 670:570 0.51 (0.32–0.82) 0.24
 Light drinkers 438:359 1266:1300 0.71 (0.35–1.44) 0.08
 Heavy drinkers 431:504 489:561 0.59 (0.39–0.90) <0.01
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OPC
Cases2
n:n
Controls2
n:n
OR (95% CI) p for heterogeneity between studies
P for heterogeneity between strata 0.74
1
Random-effects estimates were used when heterogeneity was detected, and fixed-effects otherwise. Adjusted for age, sex, race/ethnicity, 
education, study, cigarette smoking (pack-years), alcohol intake and total energy intake (as appropriate). The reference category was the lowest 
quintile of folate intake in each stratum. Calculation of cut-offs for quintile were based on distribution of controls in each study (study-specific)
2Number of subjects in the lowest quintile (I quintile): Number of subjects in the highest quintile (V quintile).
3
Europe included 2studies from Italy 29, 37 and 1from Switzerland 33. North America included 6 studies 28, 30–32, 34, 35. Asia included one 
study from Japan 36.
4
The sum does not add up to the total because of some missing values
5
Light tobacco users were smokers of ≤20 tobacco-years (combination of pack-years of cigarettes and pack-years of cigars/pipe in cigarette 
equivalent), or subjects only snuffing tobacco. Heavy tobacco users were smokers of >20 tobacco-years or subjects ever chewing tobacco.
6
Light drinkers were defined as subjects who drank <3 drinks of alcoholic beverages per day and heavy drinkers ≥3 drinks per day.
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Table 5
Odds Ratios1 and 95% confidence intervals of oral cavity and pharynx cancer (OPC) according to total folate 
intake and alcohol and tobacco consumption. International Head and Neck Cancer Epidemiology (INHANCE) 
Consortium.
Total folate intake2
Intermediate to high Low
Alcohol consumption3
 Never and light drinkers 1 (Ref) 1.32 (1.17–1.48)
 Cases: controls 1,545:6,538 902:3,286
 Heavy drinkers 3.28 (2.89–3.73) 4.05 (3.43–4.79)
 Cases: controls 1,429:1,735 680:800
Tobacco consumption
 Never tobacco users 1 (Ref) 1.33 (1.09–1.61)
 Cases: controls 429:3,059 241:1,414
 Ever tobacco users 2.11 (1.84–2.42) 2.73 (2.34–3.19)
 Cases: controls 2,471:4,799 1,299:2,435
1Adjusted for age, sex, race/ethnicity, education, study, cigarette smoking (pack-years) and total energy intake.
2
Based on tertiles of intake. Calculation of cut-offs for tertile of total folate intake were based on distribution of controls in each study (study-
specific).
3
Light drinkers were defined as subjects who drank <3 drinks of alcoholic beverages per day and heavy drinkers ≥3 drinks per day.
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